Clinical outcomes and risk factors associated with breakthrough reactions in chemotherapy desensitization.

Chemotherapy RDD was effective and safe, achieving a 96.6% success rate. The total number of desensitization procedures and skin test positivities were significant predictors of BTRs, indicating that the risk may persist despite successful initial desensitization. Careful risk assessment and close monitoring are essential to ensure patient safety during repeated RDD cycles.